ROIV
Roivant is a biotech and healthcare technology company that builds nimble, entrepreneurial companies called Vants to accelerate discovery, development, and commercialization of medicines. The group emphasizes sourcing talent, aligning incentives, and deploying technology across its portfolio to move medicines faster to patients. With a global footprint including offices in New York and Basel, Roivant operates through diverse companies focused on transformative therapies and related technologies.
No recent deals for this company.